Insider · CIK 0001871559
Marc D'Annunzio
officer
Files at BKKT (Bakkt, Inc.). First filing May 15, 2025, latest Sep 25, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $264k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BKKT: Bakkt, Inc.
BKKTOct 9, 2026 · close 6.88
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Bakkt, Inc. | $11k 1,272 shares | -1% | - | |
| 5Weak | Bakkt, Inc. | $93k 11,764 shares | -10% | +5% from low-84% from high | |
| 0Weak | Bakkt, Inc. | $7,924 785 shares | -1% | +44% from low-78% from high | |
| 30Weak | Bakkt, Inc. | $10k 559 shares | -1% | +154% from low-45% from high | |
| 39Weak | Bakkt, Inc. | $142k 10,000 shares | -13% | +84% from low-60% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | BKKT Bakkt, Inc. | AGrant or award Class A Common Stock | +45,000 | $0.00 | $0 | 152,006 | 10 d ago |
| Sep 23, 2026 | BKKT Bakkt, Inc. | SOpen-market sale Class A Common Stock | -1,272 | $8.61 | $11k | 107,006 | 17 d ago |
| Mar 27, 2026 | BKKT Bakkt, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -6,422 | $8.55 | $55k | 111,411 | Mar 31, 2026 |
| Mar 30, 2026 | BKKT Bakkt, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -5,342 | $7.08 | $38k | 106,069 | Mar 31, 2026 |
| Feb 24, 2026 | BKKT Bakkt, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -785 | $10.09 | $7,924 | 117,833 | Feb 27, 2026 |
| Nov 14, 2025 | BKKT Bakkt, Inc. | FTax withholding Class A Common Stock | -495 | $21.61 | $11k | 118,618 | Nov 18, 2025 |
| Nov 12, 2025 | BKKT Bakkt, Inc. | MOption exercise Class A Common Stock | +1,677 | $10.00 | $17k | 119,113 | Nov 14, 2025 |
| Nov 12, 2025 | BKKT Bakkt, Inc. | MOption exercise Stock Option (right to buy)derivative | -1,677 | $0.00 | $0 | 132,551 | Nov 14, 2025 |
| Nov 3, 2025 | BKKT Bakkt, Inc. | MOption exercise Class A Common Stock | +48,188 | - | - | 117,436 | Nov 4, 2025 |
| Nov 3, 2025 | BKKT Bakkt, Inc. | MOption exercise Bakkt Opco Unitsderivative | -48,188 | - | - | 0 | Nov 4, 2025 |
| Oct 31, 2025 | BKKT Bakkt, Inc. | AGrant or award Stock Option (right to buy)derivative | +134,228 | $0.00 | $0 | 134,228 | Nov 4, 2025 |
| Jul 15, 2025 | BKKT Bakkt, Inc. | SOpen-market sale Class A Common Stock | -559 | $18.21 | $10k | 69,248 | Jul 16, 2025 |
| May 14, 2025 | BKKT Bakkt, Inc. | SOpen-market sale Class A Common Stock | -10,000 | $14.21 | $142k | 69,807 | May 15, 2025 |
| Apr 28, 2025 | BKKT Bakkt, Inc. | FTax withholding Class A Common Stock | -3,501 | $8.93 | $31k | 79,807 | Apr 30, 2025 |
| Apr 11, 2025 | BKKT Bakkt, Inc. | AGrant or award Class A Common Stock | +34,211 | $0.00 | $0 | 83,308 | Apr 15, 2025 |
| Feb 19, 2025 | BKKT Bakkt, Inc. | FTax withholding Class A Common Stock | -174 | $14.84 | $2,582 | 49,950 | Feb 21, 2025 |
| Feb 19, 2025 | BKKT Bakkt, Inc. | FTax withholding Class A Common Stock | -852 | $14.84 | $13k | 49,098 | Feb 21, 2025 |
| Feb 13, 2025 | BKKT Bakkt, Inc. | AGrant or award Class A Common Stock | +3,495 | $0.00 | $0 | 50,124 | Feb 18, 2025 |
| Jan 22, 2025 | BKKT Bakkt, Inc. | FTax withholding Class A Common Stock | -809 | $28.84 | $23k | 46,976 | Feb 7, 2025 |
| Feb 5, 2025 | BKKT Bakkt, Inc. | FTax withholding Class A Common Stock | -347 | $17.56 | $6,093 | 46,629 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.